Inventor · disambiguated record
Robert Sibley
Also filed as: SIBLEY ROBERT · SIBLEY ROBERT N
22 granted patents·31 pending applications·395 citations·filing 1999–2018
95Inventor score
Top patents by PatentIndex Score
53 records- 0197US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0296US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0396US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0494US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 0591US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 0687US9242989B2Compounds as modulators of RORγBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 26, 2016·4 cites·53 claims
- 0786US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 0886US6903101B1Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Jun 7, 2005·21 cites·22 claims
- 0986US6689883B1Substituted pyridines and pyridazines with angiogenesis inhibiting activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Feb 10, 2004·20 cites·6 claims
- 1084US8093266B2Rho kinase inhibitorsDAHMANN GEORG·Filed 2008·Granted Jan 10, 2012·8 cites·11 claims
- 1184US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 1280US8946203B2Benzodioxane inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Feb 3, 2015·6 cites·16 claims
- 1375US9079880B2Rho kinase inhibitorsGINN JOHN DAVID·Filed 2011·Granted Jul 14, 2015·4 cites·11 claims
- 1474US8697911B2Rho kinase inhibitorsCOOK BRIAN NICHOLAS·Filed 2011·Granted Apr 15, 2014·3 cites·12 claims
- 1571US8450317B2CXCR3 receptor antagonistsKOWALSKI JENNIFER A·Filed 2010·Granted May 28, 2013·3 cites·5 claims
- 1666US8362249B2CXCR3 receptor antagonistsBOEHRINGER INGELHEIM INT·Filed 2010·Granted Jan 29, 2013·1 cites·2 claims
- 1765US2019002465A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1865US2008032979A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 1963US2008153823A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 2062US9598415B2Compounds as modulators of RORγBOEHRINGER INGELHEIM INT·Filed 2016·Granted Mar 21, 2017·0 cites·33 claims
- 2161US9000154B2Rho kinase inhibitorsKIRRANE THOMAS MARTIN·Filed 2011·Granted Apr 7, 2015·1 cites·11 claims
- 2261US2008300281A1Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2008·Application pending·0 cites
- 2361US2009118268A1OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORSRIEDL BERND·Filed 2008·Application pending·0 cites
- 2460US2018022749A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2559US2008194580A1Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl UreasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 2659US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 2758US2016075706A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 2858US2009093526A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2007·Application pending·0 cites
- 2957US2001027202A1Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 3055US2012046290A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 3153US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 3253US2008108672A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 3352US2012270878A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2012·Application pending·0 cites
- 3451US7977333B2Substituted pyridines and pyridazines with angiogenesis inhibiting activityBAYER HEALTHCARE LLC·Filed 2003·Granted Jul 12, 2011·0 cites·7 claims
- 3550US2001016659A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 3650US2003105091A1Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitorsFiled 2002·Application pending·0 cites
- 3750US2001034447A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 3850US2002042517A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
- 3949US2001011135A1Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4049US2001011136A1omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4148US2002137774A1Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
- 4247US2003144278A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2002·Application pending·0 cites
- 4347US2012149706A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 4446US2011263597A1Substituted pyridines and pyridazines with angiogenesis inhibiting activityBAYER HEALTHCARE LLC·Filed 2011·Application pending·0 cites
- 4545US2012040986A1Omega carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2011·Application pending·0 cites
- 4643US9573957B2Inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2014·Granted Feb 21, 2017·0 cites·3 claims
- 4743US2006004011A1Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2003·Application pending·0 cites
- 4842US9403830B2Inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Aug 2, 2016·0 cites·15 claims
- 4940US2004209924A1Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 5040US2003207914A1Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER AG·Filed 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →